Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...
Milan (ots/PRNewswire) - MainStreaming, the award-winning and innovative Edge Video Delivery Network, is proud to announce it has been named a Representative Vendor in 2025 Gartner Market Guide for Edge Computing, within the "Data Center and Cloud Edge Services" category. We believe that this recognition highlights ...
Berlin (ots/PRNewswire) - Zeotap, a leading Customer Data Platform (CDP) provider, today announces a strategic leadership realignment that will see Daniel Heer, who has served as the company's CEO since its inception, transition into the role of President, reporting directly to the Chairman. In this capacity, Daniel ...
Austin, Texas (ots) - Every year, SXSW gathers the world's boldest thinkers to offer compelling forecasts about the future. The problem? Predictions rarely come true. That's why Frederik G. Pferdt takes a different approach. Instead of predicting the future, he empowers people to create the future they want. And at SXSW, he will show you how. As a former Chief ...
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
INSIGHTEC; Charles River Laboratories International, Inc.
Wilmington, Mass., Miami and Haifa, Israel (ots/PRNewswire) - Collaboration stands to advance novel therapeutic applications across multiple neurologic conditions Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to transform ...
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
Aston Martin Lagonda of Europe GmbH
Berlin (ots) - Recognized with this year’sCES “Best of Innovation” Award in the Wearable Technologies category, Berlin-based robotics and wearable tech specialist German Bionic is back in Las Vegas in 2024 with its latest e-exoskeleton, the Apogee+ power suit. The device is specifically developed to provide ...
Takeda Pharma Vertrieb GmbH & Co. KG
Zurich (ots/PRNewswire) - - TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age of Six. - The therapeutical indication for TAKHZYRO® has been extended to patients aged 2 years and older.1 - Offers a New Preventative Treatment Option for young HAE patients with ...
WHU - Otto Beisheim School of Management
Duesseldorf (ots) - - Gerresheimer among the top 5% of assessed businesses - Total score increases to 72/100 points - Status demonstrates consistent implementation of CSR strategy Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of ...
Takeda Pharma Vertrieb GmbH & Co. KG
Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Electron microscopy: Nano-reporter proteins make invisible processes visible Genetically encoded nano-barcodes - New gene reporter system for electron microscopy - Uses barcodes to identify cellular states and structures that would otherwise remain unidentified - Important step to better elucidate cellular structural changes also in disease How do the nerve cells in our brain communicate with each other? What processes take place ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM researchers confirm assumed chamber Important find in the Cheops pyramid of Gizeh - New chamber discovered in largest of the Egyptian pyramids - Munich researchers verify long-held assumption - Function and purpose of the chamber now to be investigated An international research team has discovered a previously unknown chamber in the Cheops pyramid of Gizeh. As early as 2016 ...
